Employees Retirement System Of Texas Bluebird Bio, Inc. Transaction History

Employees Retirement System Of Texas

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$8.96 - $16.31 $59,046 - $107,482	-6,590 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $109,328 - $223,335	6,590 New	6,590 $199,000
Q4 2020 Feb 11, 2021	SELL	$27.5 - $37.92 $181,225 - $249,892	-6,590 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $391,907 - $613,529	6,590 New	6,590 $605,000

162

79.9M

525K

634K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $38.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.